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Abstract Dynamic diffusion experiments were performed
on aqueous polymeric micelles mixed with malachite green
(0.05% mass v−1), erythrosin (0.1% mass v−1), and cisplatin
(0.1% mass v−1) to gauge release from sequestered struc-
tures using ultraviolet–visible spectroscopy. The additives
were formulated with 20% mass v−1 aqueous solutions of
polyethylene oxide-polypropylene oxide-polyethylene
oxide, PEO-PPO-PEO (F127). Each additive was tested
neat at room temperature, neat at 40 C, and formulated
with F127 at room temperature, and 40 C. After construct-
ing calibration curves, the dynamic release for each ternary
additive and corresponding diffusion coefficients were cal-
culated. Results show that F127 retards permeation at room
temperature. In general, the neat additives at 40 C showed
the highest permeability for both malachite green and
erythrosin. Malachite green released almost 90% of the dye
by 60 min of permeation. When formulated with F127 at
40 C, sizeable release was still noted, but with an induc-
tion period of 10–30 min to register release. The behavior
with cisplatin was more complicated as the first 5 h of per-
meation resulted in a burst delivery with cisplatin (6% total
release with cisplatin-F127-RT compared to 4% total
release cisplatin-RT) but with overall lower release. The
higher fluence at elevated temperature is attributed to
reducing the blocking effect of the amphiphiles on the
walls of the dialysis tubing as they are directed to form col-
loidal gels. There is also likely a correlation between higher
temperature and higher overall permeability if the mem-
brane pores also expand with temperature.
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Introduction
One of the main treatments for both localized and meta-
static cancer is chemotherapy, which is used in conjunction
with surgery and radiotherapy (Guven, Rusakova, Lewis, &
Wilson, 2012). It is ideal to deliver a sufficient quantity of
drug to tumorous cells, while minimizing systemic side
effects and toxicity. However, the drug effectiveness is
retarded due to the complications with administering them
such as inefficient distribution, limited chemotherapeutic
solubility, an inability to permeate cell membranes, rapid
clearance, and the lack of selectivity between normal cells
and cancer cells (Guven et al., 2012). Cis-dichlorodiammi-
neplatinum(II) (cisplatin) is one of the most potent and
widely used anticancer drugs for treating testicular, ovarian,
bladder, cervical, head, neck, esophageal, and small-cell
lung cancers (Cepeda et al., 2007; Lebwohl & Canetta,
1998). Cisplatin interacts with DNA and interferes with the
normal cell transcription and replication processes, result-
ing in apoptosis (Cepeda et al., 2007; Siddik, 2003).
Despite its effectiveness, the clinical use of cisplatin and its
derivatives is limited due to severe systemic side effects
including nephrotoxicity, neurotoxicity, ototoxicity, nau-
sea, and vomiting (Wang & Lippard, 2005). Therefore,
developing efficient drug delivery systems that selectively
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increase the concentration of chemotherapeutics in diseased
cells and tumors are of great significance and value.
To increase the therapeutic efficacy, chemotherapeutic
drugs are often coupled with polymeric micelles and sur-
factants (Kataoka, Harada, & Nagasaki, 2001; Nasongkla
et al., 2006; Nishiyama et al., 2003). Blocky amphiphilic
copolymers with a large solubility difference between
hydrophilic and hydrophobic segments are known to
assemble in an aqueous environment into polymeric
micelles with a size range of 10–100 nm (Moffitt,
Khougaz, & Eisenberg, 1996; Munk, Prochazka, Tuzar, &
Webber, 1998; Talingting, Munk, & Webber, 1999;
Tuzar & Kratochvil, 1976). These micelles have a narrow
size distribution and are characterized by their core-shell
architecture, in which hydrophobic segments are segregated
from the aqueous exterior to form a hydrophobic inner core
surrounded by hydrophilic segments (Kataoka et al., 2001).
Interests in applying block copolymer micelles as drug
delivery systems have increased because of the high drug-
loading capacity of the inner core as well as some level of
increased tolerance of the drug-loaded micelles compared
to neat drugs (Cammas & Kataoka, 1996; Kreuter et al.,
1994; Kwon & Kataoka, 1995; Kwon & Okano, 1996;
Scholes, Coombes, Davis, Illum, & Davis, 1997). The
aggregation and surface properties of polymeric micelles in
solution depend on external factors such as pH, tempera-
ture, pressure, and the presence of additives (Verma &
Ghosh, 2011). Thus, the properties of polymeric micelles in
solution can be effectively tuned to a desired range and
application by altering these external factors. Mandal
et al. have conducted various physicochemical studies on
mixtures of PEO-PPO-PEO micelles and sodium dodecyl
sulfate (SDS) in the absence and presence of various solu-
bilized drugs, peptides, and additives as a function of vari-
ous molar compositions using various techniques (James &
Mandal, 2011; James, Ramalechume, & Mandal, 2011;
Prameela, Kumar, Aswal, & Mandal, 2013). Naskar,
Ghosh, and Moulik (2012) have also recently reported
about the effect of various additives on aqueous normal
and reverse PEO/PPO micelles. Therefore, even though
there are a variety of structures including microspheres
(Mathiowitz et al., 1997; Matsumoto, Matsukawa, Suzuki,
Yoshino, & Kobayashi, 1997), dendrimers (Gillies &
Frechet, 2005), liposomes (Allen, 1998; Ramachandran,
Quist, Kumar, & Lal, 2006; Samad, Sultana, & Aqil, 2007;
Yatvin, Weinstein, Dennis, & Blumenthal, 1978), carbon
nanohorns (Ajima et al., 2005, 2008; Murakami et al.,
2004), carbon nanotubes (Guven et al., 2012), and nanopar-
ticles; gold (Mohanty, Thennarasu, & Mandal, 2014), silver
(Mandal, Sekar, Chandrasekaran, Mukherjee, & Sastry,
2013), Fe3O4 (Cheng, Peng, Xu, & Sun, 2009; Mandal,
Sekar, Kanagavel, et al., 2013), pH-responsive compounds
(Oishi, Hayashi, Iijima, & Nagasaki, 2007; Xu et al.,
2006), and silica (Barbe et al., 2004; Slowing, Trewyn,
Giri, & Lin, 2007); that can be used as drug delivery agents,
polymeric micelles’ high drug-loading ability and toxicity
shield effect (Cammas & Kataoka, 1996; Kreuter et al., 1994;
Kwon & Kataoka, 1995; Kwon & Okano, 1996; Scholes
et al., 1997) suggests they are sufficient drug delivery plat-
forms to compliment other used drug delivery materials.
Our group has previously studied the effects a third com-
ponent has on the driving force to form polyethylene
oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-
PEO), micelles linked with thermodynamics (Thompson &
Love, 2013; Thompson & Love, 2016), structural evolution
(Meznarich, Juggernauth, Batzli, & Love, 2011), and its
gelation (Meznarich & Love, 2011). We have observed that
the third species acts as a chaperone to coerce the formation
of micelles and colloidal crystals, at lower temperature than
what forms normally in the neat stage (Meznarich et al.,
2011; Meznarich & Love, 2011; Thompson & Love, 2013,
2016). It is clear that the driving force to form a gel is influ-
enced by the third component and as phase separation
arises, the amphiphilic qualities of the additive likely have
an effect on where within the forming micelles the ternary
constituent is found (Thompson & Love, 2013, 2016). The
location of the drugs within the micelle can also affect the
permeability and bioavailability of drug elements seques-
tered within a forming colloidal gel (Thompson & Love,
2013, 2016).
Our goal is to package cold chemotherapeutic drugs in
these dispersions below their critical micelle temperatures
and inject them via syringe intratumoral, therefore, bypass-
ing an IV drip. Latent body temperature equilibration will
trigger the micelle and gelation of the copolymer and drug
within, causing the drug to be sequestered and alter the
release characteristics over time rather than from solution.
Here, we ran a series of diffusion experiments using dialy-
sis tubing cellulose membrane on aqueous polymeric
micelles (Pluronic® F127) mixed with ternary additives at
two temperatures over time to study the release characteris-
tics of micelles using ultraviolet–visible (UV–Vis) spec-
troscopy to monitor the release rate. The ternary additives
studied here are cisplatin, malachite green chloride (green
dye), and erythrosin B (red dye).
Experimental
Materials
PEO-PPO-PEO Pluronic® F127 (12,600 g mol−1 molecular
mass), malachite green chloride (C23H25ClN2, 364.91 g mol
−1
molecular mass), erythrosin B dye (C20H8I4O5, 835.89 g
mol−1 molecular weight), and cisplatin ([Pt(NH3)2Cl2],
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300.05 g mol−1 molecular mass) were all obtained from
Sigma-Aldrich (Milwaukee, WI, USA) and were used as
received. The structures of each are shown in Fig. 1. The dialy-
sis tubing cellulose membrane, also obtained from Sigma-
Aldrich (21 mm average diameter, 33 mm average flat width,
110 mL/ft capacity, 14,000 g mol−1 molecular mass cut-off ),
was soaked in deionized water at room temperature for 5 min
prior to use.
Kinetics of Release
Approximately 15 cm of cellulose membrane dialysis tub-
ing was measured and placed into 500 mL of deionized
water at room temperature for several minutes until the tube
opened. Then, one end of the tube was sealed with a rubber
band, while the other end remained open to receive the
solution. 20 mL of each solution was added to each tube
by pipette, and then the other end of the tube was sealed
with a rubber band (leaving space for a small air bubble
between the liquid and the tied knot). The outside of the
tube was rinsed with deionized water. The tube and a mag-
netic stirrer were placed into a 1000 mL beaker with
500 mL of water (either at room temperature or at 40 C)
on a hot plate. Aliquots of the receiving solution inside the
beaker were measured at various times using UV–Vis spec-
troscopy to track the release rate for each ternary additive.
A schematic representation of this setup is provided in
Fig. 2 (Team, 2017).
Neat solutions of malachite green (10 mg), erythrosin
(20 mg), and cisplatin (20 mg) were each mixed into
20 mL room temperature water and then aliquoted into the
dialysis tubing. Aqueous solutions of F127 (4 g) were each
prepared according to the “cold” processing methods of
Schmolka (1972). The ternary additives were then mixed
into each solution containing F127 and aliquoted into the
dialysis tubing. Total volume of deionized water was main-
tained by adding the same volume of fresh deionized water.
Each cumulative release profile (in the form of increasing
UV intensity vs. time) of the ternary additives was calcu-
lated from the absorption vs. concentration plots (calibra-
tion curves) for each neat ternary additive. Our cisplatin
release values are compared to Cheng et al. (2009), who
used porous hollow Fe3O4 nanoparticles for controlled
release of cisplatin. The cumulative release profile of cis-
platin was obtained via the concentration correction (the
amount of cisplatin in each aliquot was calculated to correct
the overall cumulative releasing of cisplatin) of the released
cisplatin based on the following equation (Cheng
et al., 2009):
C0t =Ct +
v
V
Xt−1
0
Ct ð1Þ
Where C0t is the corrected concentration at time t, Ct is the
apparent concentration at time t, v is the volume of the ali-
quots taken, and V is the total volume of the solution. In
this study, four separate conditions were tested for each ter-
nary additive: neat additive at room temperature
(20–25 C), neat additive at approximately 40 C (approxi-
mate Body temperature), F127 mixed additive at room tem-
perature (20–25 C), and F127 mixed additive at
approximately 40 C (approximate Body temperature).
Since each ternary additive has a different diffusion release
rate, UV–Vis spectroscopy measurements were taken
between 200 nm and 850 nm at varying times per each
OCH2CH2H O CHCH2
CH3
OCH2CH2 OH
n y n
F127 (n=100, y=65)
(a)
(c) (d) (e)
(b)
Fig. 1 (a) Pluronic® F127, (b) example of PEO-PPO-PEO micelle structure, (c) malachite green chloride, (d) Erythrosin B dye, and (e) Cis-
dichlorodiammineplatinum(II) (Cisplatin)
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condition for more accurate calculations, using a Varian
Cary 50 Bio UV–Visible Spectrophotometer (Varian Inc
(Agilent), Palo Alto, CA, USA). All UV–Vis spectroscopy
measurements for malachite green were analyzed every
10 min up to 1 h for each condition. All UV–Vis spectros-
copy measurements with erythrosin were analyzed every
30 min for up to 3 h for each condition. UV–Vis spectros-
copy measurements involving cisplatin were analyzed for
several hours throughout several days for each condition.
Results and Discussion
Calibration Curves of Ternary Additives
To study the release kinetics of the encapsulated ternary
additives in F127, we dialyzed solutions of malachite green,
erythrosin, and cisplatin in 500 mL deionized water at room
temperature and 40 C, and compared those results to dialy-
sis of dispersions containing the same small molecules with
F127 in 500 mL deionized water at room temperature and
40 C. The amount of ternary additive released from the
micelle gels was measured by UV–Vis spectroscopy. Cali-
bration curves for all the three neat ternary additives, mala-
chite green, erythrosin, and cisplatin, were calculated. Fig. 3
shows a graphical example of the calibration curve of neat
malachite green. In Table 1, we show a summary of our
values of each ternary additives’ wavelength ranges, concen-
tration ranges (mg mL−1), slopes, y-intercepts, and correla-
tion values (R2), and compare our results to the cisplatin
complex by Basotra, Singh, and Gulati (2013).
As shown in Fig. 3, as the concentration of malachite
green increases, the solution progressed from light green to
a darker green tint that absorbed in the 610–620 nm range.
This linear relationship was true for erythrosin and cisplatin
as well at other wavelengths. For erythrosin, as the concen-
tration increases, the solution progressed from light pink to
a darker pink tint that absorbed in the 520–530 nm range.
Basotra et al. (2013) mixed o-phenylenediamine with cis-
platin to form a green colored complex with wavelength
ranges 700–710 nm. For neat cisplatin, since the dissocia-
tion of the solid yellow-colored cisplatin is a clear liquid,
direct visual observation is not possible hence the impor-
tance of UV–Vis spectroscopy to measure absorbance in
the UV (270–300 nm range).
Fig. 2 Setup of dialysis tubing experiment (a) at start of dialysis (b) at equilibrium
Table 1 Wavelength ranges, concentration ranges, slopes, y-intercepts, and correlation values of malachite green, erythrosin, neat cisplatin, dark-
colored cisplatin, and cisplatin complex
Ternary Additive Wavelength
range (nm)
Concentration
Ranges (mg/mL)
Slope (Abs/conc.) y-Intercept (Abs) R2
Malachite Green 610–620 0.004 to 0.02 214.5 0.1 0.9897
Erythrosin 520–530 0.008 to 0.04 112.6 0.5 0.9356
Neat Cisplatin 270–300 0.02 to 0.22 0.3 0.008 0.9877
Dark-Colored Cisplatin 250–270 0.02 to 0.22 17.1 1.1 0.9011
Cisplatin Complex
(Basotra et al., 2013)
700–710 (Basotra
et al., 2013)
0.0004 to 0.0014
(Basotra et al., 2013)
0.00022 (Basotra
et al., 2013)
8.0 x 10−7 (Basotra
et al., 2013)
0.9999 (Basotra
et al., 2013)
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The dynamic rise in absorption in the receiver solution
was used to calculate the concentration of the diffused mol-
ecules in solution at a given time. During dialysis, aliquots
of the solution were measured by UV–Vis spectroscopy to
resolve a receiving solution concentration. The cumulative
release of neat ternary additives and ternary additve-F127
at room temperature and 40 C is shown in Figs. 4,5,
and 6.
For cisplatin, unexpectedly during our experimentation,
observable dark black particles formed both inside and out-
side the dialysis tubing floating around in the receiver solu-
tion. This indicates a reaction is occurring and forming
dark-colored precipitate that eventually settled at the bot-
tom of the beaker. Both the neat cisplatin trials and the
cisplatin-F127 experiments resulted in precipitation occur-
ring faster and more obviously in the dispersion than in the
neat solution. These observations suggest cisplatin is unsta-
ble in solution. The instability is more pronounced at ele-
vated temperatures and encapsulating cisplatin in a
polymeric micelle might be ineffective in somehow stabi-
lizing cisplatin from its transformation potential. We previ-
ously opened an old, stored sample of unused cisplatin and
noticed similar discoloration. Upon reviewing the literature,
Cubells, Aixela, Brumos, Pou, and Flaque (1993) con-
cluded cisplatin is unstable in aqueous solutions and the
primary mode of decomposition involves displacement of
the chloride ligand, so increasing the chloride ion concen-
tration would likely improve the stability of the drug in
aqueous solution (Banerjea, Basolo, & Pearson, 1957;
Cubells et al., 1993; Lee & Martin, 1976; Reishus, Don, &
Martin, 1961). We performed a calibration curve for the
dark-colored cisplatin and the results are shown in Table 1.
Interestingly, the absorbance was much higher at the same
concentrations for the dark-colored cisplatin compared to
the normal yellow-colored cisplatin at slightly different
wavelength ranges (250–270 nm for dark-colored com-
pared to 270–300 nm for neat cisplatin) which is indicated
in Table 1 by their different slopes (0.3 for neat cisplatin
compared to 17.1 for dark-colored cisplatin). Since the
dark-colored particles were observed throughout the
experiment for every condition, the calibration curve for
dark-colored cisplatin was used in Fig. 6 instead of the cali-
bration curve results for neat cisplatin to calculate the con-
centration of diffused cisplatin in solution at a given time.
y = 214.45x - 0.1478
R2 = 0.9897
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Fig. 3 Neat malachite green absorption vs. concentration calibration
curve. Absorption analysis were measured in 500 mL deionized water
using UV–Vis spectroscopy at wavelengths 610–620 nm
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Fig. 4 Release of neat malachite green, MG, and malachite green-
F127, MG-F127, at room temperature, RT, and 40 C over time. Each
condition the malachite green released was measured in 500 mL deio-
nized water by UV–Vis spectroscopy at wavelengths 610–620 nm
0
10
20
30
40
50
60
70
80
0 30 60 90 120 150 180 210
R
el
ea
se
d 
E
ry
th
ro
si
n 
(%
)
Time (minutes)
ER-RT
ER-40°C
ER-F127-RT
ER-F127-40°C
Fig. 5 Release of neat erythrosin, ER, and erythrosin-F127, ER-F127,
at room temperature, RT, and 40 C over time. Each condition of the
erythrosin released was measured in 500 mL deionized water by UV–
Vis spectroscopy at wavelengths 520–530 nm
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Fig. 6 Release of neat cisplatin and cisplatin-F127 at room tempera-
ture, RT, and 40 C over time. Each condition of the cisplatin released
was measured in 500 mL deionized water by UV–Vis spectroscopy at
wavelengths 250–270 nm.
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The Kinetics of Malachite Green Release
To study the release kinetics of the encapsulated malachite
green in F127, we dialyzed neat malachite green in deionized
water at room temperature and 40 C and compared those
results to the dialyzed malachite green-F127 in deionized
water at room temperature and 40 C. The amount of mala-
chite green released from the micelle gels was measured by
UV–Vis spectroscopy at wavelengths 610–620 nm as shown
in Fig. 4.
The most valuable outcome of this type of analysis is
probably the ability to extract a mass diffusion coefficient
measurement for each condition, the determinations of
which are shown in Table 2. The thickness of the mem-
brane and the surface area of the dialysis tube are needed to
perform the calculation. Clearly, mass transfer is the easiest
(highest diffusion coefficient) for the MG-40 C without
the amphiphile. Adding the amphiphile, MG-F127-40 C,
cuts the flux in half but as time went on later in this experi-
ment, there was a noted rise in the permeation rate. Similar
release characteristics were observed in the neat MG-RT
sample. The most sluggish diffusion occurred when the
amphiphiles were added and diffusion commenced at room
temperature. One observable was that none of these experi-
ments achieved a saturation dose over the evaluated time
scale. Clearly, the driving force for continued permeation
existed for all experiments and we cannot comment on
whether there was a difference in total release.
The rationale for elevated temperature leading to higher
permeation is clear. There is higher Brownian motion in
the solution when the temperature is raised from room tem-
perature to 40 C, and it is possible that the pore dimen-
sions grow to make the membrane more permeable with
higher temperature as well. The increased activity of the
higher temperature solution explains why the neat solutions
show higher flux and a higher apparent diffusion coefficient
at higher temperature.
The presence of the amphiphile has two likely physical
outcomes. At elevated temperature, there is clearly enough
energy to trigger the formation of the colloidal crystals and
the more the amphiphiles are organized into bulk structures
in solution, the lower the probability that the surfactants are
bound to the wall of the membrane blocking MG transport.
If the amphiphiles organize into hydrophobic cores, those
regions are effectively excluded volumes for aqueous solu-
ble MG, which will raise the concentration in the water
phase and increase the mass flux across the boundary.
Of course, if MG was strongly bound to regions of the
amphiphiles because micelles have larger micellar hydro-
dynamic radii at elevated temperatures, there might be a
lower driving force for allowing MG to permeate out of the
dispersion. Clearly, lower transport was not observed.
Lower temperature lowers the driving force for forming
micelles and gels. Our group has pointed out that the typi-
cal micelle formation temperatures dropped with higher
concentrations of F127 and with some ternary additives that
Table 2 Diffusion coefficient of each experimental condition: Neat malachite green, MG, erythrosin, ER, and cisplatin (first 5 h) and mixed
F127 at room temperature, RT, and 40 Ca
Experimental condition Diffusion coefficient (cm2 s−1)
MG-RT 2.6  0.01 × 10−7
MG-F127-RT 2.6  0.01 × 10−8
MG-40 C 7.9  0.1 × 10−7
MG-F127-40 C 5.2  0.01 × 10−7
ER-RT 4.7  0.01 × 10−8
ER-F127-RT 3.7  0.1 × 10−9
ER-40 C 5.2  0.01 × 10−7
ER-F127-40 C 1.0  0.01 × 10−6
Cisplatin-RT (5 h) 6.7  0.01 × 10−6
Cisplatin-F127-RT (5 h) 3.0  0.1x 10−7
Cisplatin-40 C (5 h) 0
Cisplatin-F127-40 C (5 h) 1.2  0.1 × 10−6
Cisplatin-PLGA nanoparticles (150 h) 4.1 × 10−17 (Reardon et al., 2017)
Cisplatin-PLGA microspheres (500 h) 4.8 × 10−13 (Campbell et al., 2016)
Cisplatin-PLGA solid fibers (200 h) 6.1 × 10−10 (Campbell et al., 2016)
Cisplatin-PLGA hollow fibers (400 h) 3.3 × 10−10 (Campbell et al., 2016)
Cisplatin-chitosan-alginate nanoparticles (t < 2 h) 8.2 × 10−1 (average) (Maan et al., 2016)
a Our results are compared to the in vitro release of cisplatin from core-shell poly(lactide-co-glycolide) (PLGA) nanoparticles (Reardon et al.,
2017), PLGA microspheres, solid fibers, and hollow fibers (Campbell et al., 2016), and electrostatically cross-linked chitosan-alginate nanopar-
ticles (Maan et al., 2016)
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interact with the micelle regulating the energetics of micelle
formation (Meznarich et al., 2011; Meznarich & Love,
2011; Thompson & Love, 2013, 2016). If the driving force
to form micelles is small, it is quite possible that more
adsorbed surfactant is blocking pores in the membrane.
Clearly, the lower temperature is also reducing the
Brownian motion as well, but comparing MG-RT and MG-
F127-RT, the presence of the surfactant is a strong impedi-
ment to permeation. Considering F127 reduced the release
rate of malachite green at room temperature and 40 C, this
suggests it would offer a desired platform for drug delivery
and release.
The Kinetics of Erythrosin Release
To study the release kinetics of the encapsulated erythrosin
in F127, we dialyzed neat erythrosin in deionized water at
room temperature and 40 C and compared those results to
the dialyzed erythrosin-F127 in deionized water at room
temperature and 40 C. The amount of erythrosin released
from the micelle gels was measured by UV–Vis spectros-
copy at wavelengths 520–530 nm shown in Fig. 5.
The diffusion coefficient measurements for each erythro-
sin condition are provided in Table 2. Similar to malachite
green, the highest flux for erythrosin is ER-40 C without
the amphiphile. Adding the amphiphile, ER-F127-40 C,
cut the flux in half but as time went on in the experiment,
there was a noted burst in the permeation rate. There was
no observable change in the release characteristics between
the neat ER-RT and ER-F127-RT samples as both showed
very low release (below 10%).
Similar to malachite green, none of these experiments
achieved a saturation dose over the evaluated time scale.
The driving force for continued permeation existed for all
the experiments, but we cannot comment on whether there
was a difference in total release. At 40 C, once again the
Brownian motion is higher, and that explains why the dif-
fusion coefficient for ER-40 C is the highest in the neat
conditions for the first 150 min.
The presence of the amphiphile at elevated temperature
cut the mass transfer rate in half for the first 150 min. There
was enough energy to form colloidal crystals, lowering the
probability that the surfactants were bound to the wall of
the membrane blocking the ER transport. If ER was
strongly bound to the regions of the amphiphiles, there
might be a lower driving force for allowing ER to permeate
out of the dispersion. This was not observed as a diffusion
coefficient of 1.0  0.01 × 10−6 cm 2 s−1 was found under
this condition. After 150 min, we observed an increasing
release of ER that was not observed with MG making the
overall dynamic release curve more nonlinear. The molecu-
lar mass of ER is larger than that of MG, so it takes longer
for ER molecules to percolate through the gel and the
membrane. This is an indication that while F127 does have
a diffusion rate limiting effect on ternary additives, the rate
at which the diffusion is limited varies for each ternary
additive due to the molecular mass of the ternary additives.
According to Mandal (1987), translational and rotational
motion diffusion coefficients can occur in solution simulta-
neously either in series or parallel. In congested polymeric
micellar conditions, there is a possibility of self-diffusion
(slow process) and mutual or collective diffusion (fast pro-
cess). These conditions are indistinguishable when the
small amount of supporting electrolytes and buffer solu-
tions are present in the systems (Geetha & Mandal, 1995,
1997; James, Ramalechume, & Mandal, 2005; Mandal,
1993; Mandal & Nair, 1991). With the method used here, a
diffusion coefficient can be determined, but the nonlinearity
of the ER release suggests it is non-Fickian and a different
model is more appropriate.
Lowering the temperature lowers the driving force for
forming micelles and gels. If the driving force to form
micelles is small, it is possible that more adsorbed surfac-
tant is blocking the pores in the membrane. The lower tem-
perature also reduces the Brownian motion. In this case, for
ER-RT and ER-F127-RT, the driving force for diffusing
ER is so low at room temperature that similar results were
observed with and without the amphiphile. Considering
F127 still reduced the release rate of ER in both conditions,
this is another indication that suggests it would offer a
desired platform for drug delivery and release.
Conceptually, erythrosin permeation through the dialysis
membranes has a similar profile to MG. The hydrophilic
erythrosin is concentrated in the aqueous regions and
excluded from the hydrophobic cores of the micelles,
which increases the concentration gradient across the dialy-
sis membrane once micelles form. And at elevated tempera-
ture, the pores in the membrane are larger.
The Kinetics of Cisplatin Release
The same protocol was used for dialyzed neat cisplatin in
deionized water at room temperature and 40 C and com-
pared to that of dialyzed cisplatin-F127 in deionized water
at room temperature and 40 C. The amount of cisplatin
released from the micelle gels was measured by UV–Vis
spectroscopy at wavelengths 250–270 nm as shown in
Fig. 6. The cumulative release results in general compares
well to previous cisplatin encapsulated drug delivery sys-
tems (Cheng et al., 2009; Czarnobaj & Lukasiak, 2007;
Fang, Chen, Leu, & J-W, 2008; Guven et al., 2012; Rear-
don et al., 2017). Guven et al. (2012) reported less than
25% total released cisplatin from their Pluronic® F108-
wrapped, W-CDDP@US-tubes after 200 h. Cheng
et al. (2009) reported less than 10% total cisplatin release
from their Fe-cisplatin loaded nanoparticles, Pt-PHNPs, at
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pH 7.4, 6, and 5 after 70 h. Reardon et al. (2017) reported
less than 20% cumulative release of cisplatin after 10 h
from their core-shell poly(lactic-co-glycolic acid) (PLGA)
nanoparticles. Fang et al. (2008) reported less than 25%
total cisplatin release from their chitosan hydrogels after
5 h. Czarnobaj and Lukasiak (2007) reported less than 50%
cisplatin release after 20 h from their silica (SiO2) xerogels
at room temperature and 120 C.
The diffusion results were unlike a normal diffusion pro-
file. We observe a burst condition for three of the solution
conditions including cisplatin neat (cisplatin-RT) in water at
25 C, and for both dispersions (cisplatin-F127-RT and
cisplatin-F127-40 C)) at ambient temperature and at 40 C.
Reardon et al. (2017) and Fang et al. (2008) both also
observed an initial burst release of cisplatin from their core-
shell PLGA nanoparticles and chitosan hydrogels. It is
worth noting that the size of the initial burst release is on the
order of 8–9% while the neat MG and erythrosin release
substantially more over the 150 h of experimentation. We
calculated a diffusion coefficient for the short, initial burst
phase, but it is clear that three of the four conditions, there is
burst followed by a much smaller release, compared with
the systematic release of other dye molecules. The diffusion
coefficient measurements for each cisplatin condition are
provided in Table 2. From the analysis, the highest flux
observed for cisplatin was cisplatin-F127-RT. The cisplatin-
F127-RT release was slightly higher than cisplatin-RT.
There was no observable diffusion for neat cisplatin-
40 C in the first 5 h. However, cisplatin was observed at
much longer times, finally permeating through after 50 h.
More Brownian motion should occur in the higher tempera-
ture neat systems but there may be a larger driving force to
also transform and precipitate neat cisplatin as opposed to
driving it across the dialysis membrane.
The presence of the amphiphile at elevated temperature
increased the permeation for the first 5 h relative to the neat
system. This is possibly due to F127 interacting with cis-
platin as we observed the formation of dark-colored parti-
cles floating around in solution. If cisplatin was strongly
bound to hydrophilic or hydrophobic regions of the amphi-
philes, there might be a lower driving force to allow cis-
platin to permeate out of the dispersion. This was not
observed, as a diffusion coefficient of 1.20.1×10−6 cm2 s−1
was found under this condition. Continued release past the
burst period is observed and indications of a plateau con-
centration are evident at approximately 8% drug release at
longer times. So a little less than half the release comes in
the first 5 h and the rest with longer exposure.
Lowering the temperature lowers the driving force for
forming micelles and gels. The lower temperature also
reduces the Brownian motion. We observed a slightly higher
initial burst at room temperature for the dispersion (F127-
cisplatin RT) relative to the neat solution (cisplatin-RT).
Since continued release of cisplatin occurred over time even
after the initial burst, (3% release after 5 h compared to 8%
release after 144 h), the presence of the amphiphile may aid
in transporting cisplatin across a membrane.
Only with the dispersion at elevated temperature
(cisplatin-F127-40 C) is a plateau in permeation observed.
There is a noted decrease in UV–Vis absorption for the
other three conditions. Clearly with black particles forming
while conducting the diffusion experiments, one rationale
for the lower absorption at later times might be the sedi-
mentation of converted cisplatin particles that are not sus-
pended in solution. If particles are denser than the fluid
medium of the receiver solution, it is possible that the parti-
cles drift to the bottom of the receiver solution and are not
sensed as part of the absorption at later time. If there was a
nucleation and growth mechanism regulating particle for-
mation, and if the particles grew in size with time, they
might be separated in the two-phase dispersion of particles
in the receiver reservoir. We observed significant particle
accumulation at the bottom of the reservoir as well. If the
particle formation is linked with the inactivation of cis-
platin, perhaps doing the experiments in saline solution
might preserve the activity of the cisplatin and keep it in
solution as opposed to directing its formation of a second
particle phase as a dispersion.
Comparing the molecular structures of cisplatin with
MG and ER, the two dyes are both stable and hydrophilic,
while cisplatin is clearly unstable and perhaps more ambig-
uous in terms of its overall hydrophilicity. If the same
mechanism of liberating the pores occurs with the amphi-
phile coalescence and formation of hydrophobic cores, if
cisplatin was more drawn to the interface between the core
and shell, that would reduce the amount available at the
membrane boundary. With a time-dependent stability issue,
even if cisplatin was labile outside of the cores within the
dialysis membrane, the fact that there is a nucleation and
growth of the dark particulates that quickly grew larger
than the pore dimensions of the membrane.
Comparison to Other Permeation Experiments
Table 2 presents our results and includes a comparison of
cisplatin diffusion coefficient values in a variety of delivery
systems. The table includes references for cisplatin released
from PLGA nanoparticles (Reardon et al., 2017), PLGA
microspheres, solid fibers, and hollow fibers (Campbell,
Delgado-Charro, Camus, & Perera, 2016), and chitosan-
alginate nanoparticles (Maan, Bajpai, & Bajpai, 2016).
Our diffusion results are higher than Campbell
et al. (2016) who observed much slower cisplatin diffusiv-
ity from PLGA microspheres. Campbell’s lower diffusivity
of cisplatin was caused by the low molecular mobility of
the matrices where cisplatin is encapsulated. Campbell
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et al. reported some microspheres engulfed other micro-
spheres, with shell-like pores surrounding some regions of
a microsphere causing droplets of oil to disperse in the
aqueous phase. The low porosity of these microspheres
suggests more sluggish drug permeability as there are few
aqueous channels to allow paths for drug escape (Campbell
et al., 2016). Campbell also observed a cumulative drug
release over 500 h, while our reported diffusion coefficient
numbers are within the first 5 h of release.
Our diffusion results are also higher than those reported
by Campbell et al. (2016) for diffused cisplatin from PLGA
solid and hollow fibers. Campbell et al. reported that during
fiber drying, as more solvent is extracted during the phase
inversion, the oil phase becomes a poorer solvent to the
polymer chains, and the chains retract and interact more
with each other causing the glass transition temperature, Tg,
to increase. Since the polymer chains are less mobile, the
diffusivity of the solvent in the oil phase decreases thus
reduces the volume of the core, causing lower drug release
(Campbell et al., 2016). Campbell et al. also observed a
cumulative drug release over 200 h for solid fibers, and
400 h for hollow fibers.
Our diffusion coefficients appear quite low, relative to
Maan et al. (2016) for in vitro release of cisplatin from
electrostatically cross-linked chitosan-alginate nanoparti-
cles. This discrepancy could be due to the differences in
our controlled drug release methods. Our polymeric
micelles form gels at elevated temperatures, which encap-
sulates cisplatin, thus significantly reducing its permeation.
Maan et al.’s release of the cisplatin complex from the
nanoparticles involves the absorption of water into the
nanoparticles matrix and simultaneous release of the drug
via diffusion. When Maan’s drug encapsulated nanoparti-
cles are exposed to water, the polymer swells, causing the
Tg of the polymer to drop relative to the experimental tem-
perature (Maan et al., 2016). The release of the drug is reg-
ulated by the process of relaxation of macromolecular
chains and the diffusion of the entrapped drug molecules
into the exterior medium (Maan et al., 2016). The Maan
effort was tied to diffusion on a molecular level and our
membrane dimensions are in the order of 100 μm, much
larger overall. Maan et al. also observed a cumulative drug
release within 2 h, while our reported diffusion coefficient
numbers are within the first 5 h of release.
Our diffusion results are also very low compared to Rear-
don et al. (2017) for cisplatin release from core-shell PLGA
nanoparticles. This discrepancy could be due to the fact that
Reardon et al. observed their cumulative release over 150 h
compared to our calculations after 5 h. The Reardon effort
also fabricated a drug delivery system on the nanoscale
while our system is on the microscale. Reardon et al. also
observed their diffusion study in phosphate-buffered saline
(PBS) while our study was observed in deionized water.
Conclusions
In summary, we demonstrated an approach using amphi-
philic polymeric micelles (F127) to regulate controlled
release of two indicator dyes (malachite green and erythro-
sin) and one chemotherapeutic drug (cisplatin). We tested
the release at temperatures that would alter the driving
force for forming colloidal gels in vivo (room temperature
and 40 C). We show the process tracking dye or drug col-
lection in a receiver solution through a dialysis membrane
from the absorbance measurements, via UV–Vis spectros-
copy, to the determination of an apparent diffusion coeffi-
cient where applicable. Our cisplatin results were compared
to a number of other studies in which permeation in a
sequestered nanostructure was evaluated for its fluence
(Campbell et al., 2016; Maan et al., 2016). Adding the
amphiphile lowered the permeability of dye molecules
(2.6  0.01 × 10−7 cm2 s−1 MG-RT compared to 2.6 
0.01 × 10−8 cm2 s−1 MG-F127-RT), but tended to result in
a burst delivery with cisplatin (6% total release with
cisplatin-F127-RT compared to 4% total release cisplatin-
RT). We noted instability with cisplatin in aqueous solution
(Banerjea et al., 1957; Cubells et al., 1993; Lee & Martin,
1976; Reishus et al., 1961).
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